FDA approves Lupin Tramadol HCl ER Tablets ANDA
Tramadol HCl ER is a centrally acting synthetic analgesic in an extended release formulation. Tramadol HCl ER is generic equivalent to Ultram ER Tablets of Ortho-McNeil-Janssen Pharmaceuticals which

Tramadol HCl ER is a centrally acting synthetic analgesic in an extended release formulation. Tramadol HCl ER is generic equivalent to Ultram ER Tablets of Ortho-McNeil-Janssen Pharmaceuticals which

PrimeMobile incorporates functionality accessed on handheld devices with Greenway’s single-database electronic health record (EHR), practice management and interoperability solution – PrimeSuite. PrimeMobile’s administrative and financial capabilities integrate charge

Lipitor, known generically as Atorvastatin Calcium tablets, are a type of cholesterol-lowering medicine called a statin, which block an enzyme in the liver that the body uses to

The trial involves around 132 healthy subjects with head lice infestation, 2 years of age and older, in two study centers in the US. DeOvo, a topical formulation

Magellan’s Medical Pharmacy Solutions program is operated by its specialty pharmaceutical division, Icore Healthcare. The accreditation provides assurance to patients, providers, purchasers, regulators and employers that the practices

TMC435, an investigational CHC protease inhibitor currently in phase 3 clinical development, is a highly potent, selective and safe once-daily (q.d.) drug jointly developed by Tibotec Pharmaceuticals to

Perampanel is an orally administered, highly selective non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptor antagonist discovered and being developed by Eisai. In Study 305, the response rates (defined as

The company is developing an antigen found in most human cancers. Sirona CEO Howard Verrico said vaccines using these antigens have the potential to treat and prevent many

Anatabloc, which contains dietary ingredient anatabine citrate, is developed by Rock Creek Pharmaceuticals, a subsidiary of Star Scientific. The company has submitted a provisional patent application with the

episil is a patented oral spray indicated for local treatment of pain related to oral mucositis. The tie up allows Teva to commercialize episil in Germany, Spain, Poland,